Skip to main content

Want a detailed portfolio tracker?

Solid Biosciences (SLDB) P/E (2018 - 2026)

Solid Biosciences (SLDB) P/E from Apr 2, 2018 to Jul 21, 2026. The TTM Solid Biosciences (SLDB) P/E is -3.67. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Solid Biosciences (SLDB)

YearP/EChange
2026-3.67+45.46%
2025-2.52+101.07%
2024-1.26-6.23%
2023-1.34+22.26%
2022-1.10-88.57%
2021-9.58-76.91%
2020-41.50+70.34%
2019-24.36-87.21%
2018-190.49N/A

Comparison Solid Biosciences (SLDB) P/E with competitors

Solid Biosciences (SLDB) P/E is -3.67.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.12%
ENLVEnlivex Ltd0.07-102.04%
FGENFibroGen Inc0.24-106.54%
CHRSCoherus Biosciences Inc0.85-123.11%
FBIOFortress Biotech Inc0.95-125.84%
ORMPOramed Pharmaceuticals Inc1.50-140.93%
AGENAgenus Inc3.01-181.95%
INVAInnoviva Inc3.15-185.88%
VXRTVaxart Inc3.55-196.66%
CRMDCorMedix Inc3.63-198.80%
CVACCureVac N.V.4.45-221.05%
GLPGGalapagos NV4.86-232.31%
SRPTSarepta Therapeutics Inc4.88-232.94%
ABEOAbeona Therapeutics Inc5.39-246.70%
ABUSArbutus Biopharma Corp5.60-252.37%
ZVRAZevra Therapeutics Inc5.89-260.31%
SPROSpero Therapeutics Inc6.23-269.60%
CGENCompugen Ltd6.31-271.93%
RIGLRigel Pharmaceuticals6.87-287.12%
SLXNSilexion Therapeutics Corp7.30-298.67%
OMEROmeros Corporation9.26-352.11%
AUPHAurinia Pharmaceuticals Inc9.58-361.00%
PLXProtalix BioTherapeutics Inc10.89-396.56%
ACADAcadia Pharmaceuticals Inc11.73-419.36%
TBPHTheravance Biopharma Inc12.26-433.89%
ADMAAdma Biologics Inc12.42-438.14%
HRMYHarmony Biosciences Holdings Inc13.82-476.32%
SABSSAB Biotherapeutics Inc14.14-484.93%
NAGENiagen Bioscience Inc14.82-503.49%
INCYIncyte Corp15.82-530.84%
REGNRegeneron Pharmaceuticals Inc15.86-531.77%
PBYIPuma Biotechnology Inc17.32-571.50%
CPRXCatalyst Pharmaceuticals Inc17.44-574.87%
EXELExelixis Inc17.54-577.56%
TGTXTG Therapeutics Inc18.97-616.44%
MDXGMimedx Group Inc20.55-659.64%
XOMAXOMA Royalty Corp22.87-722.89%
ARGXArgen X SE24.30-761.65%
CTMXCytomX Therapeutics Inc24.82-775.89%
XOMAOXOMA Royalty Corp25.34-790.15%
HALOHalozyme Therapeutics Inc25.62-797.75%
XOMAPXOMA Royalty Corp25.67-799.01%
VRTXVertex Pharmaceuticals Inc27.99-862.31%
RPRXRoyalty Pharma plc - Class A28.69-881.18%
SLNOSoleno Therapeutics Inc29.02-890.10%
ASNDAscendis Pharma A/S30.09-919.24%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1132.36%
APLSApellis Pharmaceuticals Inc39.02-1162.57%
BMRNBiomarin Pharmaceutical Inc42.21-1249.45%
KRYSKrystal Biotech Inc45.34-1334.73%
ONCBeiGene Ltd69.54-1993.62%
PHARPharming Group N.V.75.03-2142.98%
TECHBio-Techne Corp101.96-2876.38%
VCELVericel Corp109.92-3093.21%
ALNYAlnylam Pharmaceuticals Inc117.96-3312.25%
GMABGenmab140.29-3920.19%
TLXTelix Pharmaceuticals Ltd162.15-4515.50%
CORTCorcept Therapeutics Inc212.86-5896.22%